Brief: Karolinska Development Portfolio Co Boost Pharma Completes Pre-Ind Meeting With FDA, Gets Second Tranche Of Investment

Kdventures AB

05/11/2024 07:17

Nov 5 (Reuters) - Karolinska Development AB  KDEV.ST :
    * KAROLINSKA DEVELOPMENT'S PORTFOLIO COMPANY BOOST PHARMA
SUCCESSFULLY COMPLETES PRE-IND MEETING WITH FDA AND RECEIVES
SECOND TRANCHE OF INVESTMENT
    * POSITIVE OUTCOME FROM MEETING WILL TRIGGER SECOND TRANCHE
OF
KAROLINSKA DEVELOPMENT'S INVESTMENT IN BOOST PHARMA
    * KAROLINSKA DEVELOPMENT'S OWNERSHIP IN BOOST PHARMA WILL
AMOUNT
TO 10% FOLLOWING SECOND TRANCHE

Source text:  ID:nGNE5vpM8M 
Further company coverage:  KDEV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))